Therapy News and Research

RSS

Women with epilepsy should not let their condition stop them from planning a family

Generally speaking, women with epilepsy should not let their condition stop them from planning a family, according to doctors and epilepsy researchers.

27 Jul 2004

Definite link between migraine and menstruation

Two new studies shows a definite link between migraine and menstruation. Approximately half of all women who seek clinical treatment for migraines have reported an association between migraine and menstruation, and a recent study by the City of London Migraine Clinic confirms their experience.

26 Jul 2004

FDA approval for VYTORIN for the treatment of high LDL cholesterol (LDL-C)

Merck/Schering-Plough Pharmaceuticals has announced that the U.S. Food and Drug Administration has approved VYTORIN™ (ezetimibe/simvastatin) for the treatment of high LDL cholesterol (LDL-C) in patients with primary hypercholesterolemia or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough.

26 Jul 2004

Innovative treatment for cancer patients who have previously undergone chemotherapy, surgery or radiotherapy

At the inauguration of Hadassah's new day care center of the Sidney Weisner Department of Bone Marrow Transplantation and Cancer Immunotherapy today, Prof. Shimon Slavin, head of the department, described an innovative treatment for cancer patients who have previously undergone chemotherapy, surgery and/ or radiotherapy.

26 Jul 2004

Janssen Pharmaceutica has sent a letter to health care providers to clarify the risks involved with the use of RISPERDAL®

Janssen Pharmaceutica, the maker of RISPERDAL® (risperidone), the most frequently prescribed antipsychotic medication in the U.S., has sent a letter to health care providers to clarify the risks involved with the use of RISPERDAL®.

26 Jul 2004

Light-sensitive probe to help doctors spot breast cancer

A light-sensitive probe is being developed to help doctors spot breast cancer in some of the 70,000 American women each year whose malignancies fail to show up in needle biopsies.

26 Jul 2004

Correlation between caffeine intake at mealtime and increased glucose and insulin levels among diabetics

Duke University Medical Center researchers at have found a strong correlation between caffeine intake at mealtime and increased glucose and insulin levels among people with type-2 diabetes.

26 Jul 2004

Emerging nanomedicine technologies could dramatically transform medical science

Emerging nanomedicine technologies could dramatically transform medical science as we know it today with their potential to address unmet medical needs and provide targeted therapy.

23 Jul 2004

$1.6 million to develop gene therapy strategies for Duchenne muscular dystrophy, a fatal, childhood-onset disease

The Muscular Dystrophy Association has announced it has awarded $1.6 million to Asklepios, a biotechnology company closely allied with the University of North Carolina at Chapel Hill, to develop gene therapy strategies for Duchenne muscular dystrophy (DMD), a fatal, childhood-onset disease.

23 Jul 2004

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Within the next five years, international organizations and world leaders should begin collectively to contribute $300 million to $500 million annually to create a global subsidy that would make new combination malaria treatments available to the world's poor for as little as 10 cents per treatment course

23 Jul 2004

Trial sparks debate over treatment of diabetic hypertensives

A major new international study published in the Journal of Hypertension has challenged traditional thinking by revealing that the thiazide-like diuretic indapamide SR (Natrilix SR) has equivalent efficacy to enalapril in reducing microalbuminuria (MA) in patients with type 2 diabetes.

22 Jul 2004

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Erbitux (cetuximab), offers another option for patients who have colorectal cancer that resists standard chemotherapy treatment, according to an article written by two Mayo Clinic cancer researchers published in the current edition of the New England Journal of Medicine.

21 Jul 2004

Bladder-sparing treatment shows promise against cancer

For patients with invasive bladder cancer, treatment has typically meant an operation to remove the bladder and nearby organs. This requires up to a week in the hospital and leaves patients with a reconstructed bladder or urostomy bag.

21 Jul 2004

Clinical study compares treatments in early Parkinson's disease

University of Tennessee Health Science Center professor and vice chair of the Department of Neurology, Ronald F. Pfeiffer, M.D., has been an investigator with The Parkinson Study Group (PSG), which recently reported four-year results of a major long-term, multi-center clinical trial.

21 Jul 2004

Australian collaboration to produce cancer immunotherapy vaccines

A Brisbane based biomedical company, Tissue Therapies Limited (TIS) and the Queensland Institute of Medical Research (QIMR) have agreed on the terms of a new collaboration aimed at developing Tissue Therapies' VitroGro® cell growth technology as a platform to produce cancer immunotherapy vaccines.

21 Jul 2004

Psychotherapist offering equine-assisted psychotherapy

Psychotherapists employ a variety of methods to aid in their patients’ recovery, ranging from conversation to medication to hypnosis to horses. Yes - horses!

21 Jul 2004

New measurement tool to help treat vitiligo

Superstar Michael Jackson and more than 40 million others who suffer from a de-pigmenting skin disease now have a better way to predict the effectiveness of treatment, thanks to a clinical measurement tool created by a University of British Columbia dermatology researcher.

21 Jul 2004

A new vaccine that may delay cancer recurrence

A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence

21 Jul 2004

Roche files for application with FDA to market hepatitis C medication Pegasys(R) for chronic hepatitis B treatment

Roche announced today the submission of a supplemental new biologics license application (sBLA) with the U.S. Food and Drug Administration to market Pegasys(R) (peginterferon alfa-2a) for the treatment of chronic hepatitis B (CHB).

21 Jul 2004

We know they need caffeine, but how it works on the newborn is the subject of a new study

Every morning, millions of adults consume voluminous cups of coffee, seeking the jolting effect of caffeine. As these adults consume their coffee, they do so unaware that some of the youngest Americans are also getting a treatment of caffeine - not to stay awake, but to assist in treating a major sleep disorder found in some neonates.

21 Jul 2004

Therapy News and Research

Women with epilepsy should not let their condition stop them from planning a family

Definite link between migraine and menstruation

FDA approval for VYTORIN for the treatment of high LDL cholesterol (LDL-C)

Innovative treatment for cancer patients who have previously undergone chemotherapy, surgery or radiotherapy

Janssen Pharmaceutica has sent a letter to health care providers to clarify the risks involved with the use of RISPERDAL®

Light-sensitive probe to help doctors spot breast cancer

Correlation between caffeine intake at mealtime and increased glucose and insulin levels among diabetics

Emerging nanomedicine technologies could dramatically transform medical science

$1.6 million to develop gene therapy strategies for Duchenne muscular dystrophy, a fatal, childhood-onset disease

Malaria mortality rate in Africa and Asia could double in a few decades as the drug used most frequently is rendered useless

Trial sparks debate over treatment of diabetic hypertensives

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Bladder-sparing treatment shows promise against cancer

Clinical study compares treatments in early Parkinson's disease

Australian collaboration to produce cancer immunotherapy vaccines

Psychotherapist offering equine-assisted psychotherapy

New measurement tool to help treat vitiligo

A new vaccine that may delay cancer recurrence

Roche files for application with FDA to market hepatitis C medication Pegasys(R) for chronic hepatitis B treatment

We know they need caffeine, but how it works on the newborn is the subject of a new study

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News